Physician

Julia G Ansari, M.D.

According to 2025 Medicare claims, Julia Ansari, M.D. (NPI: 1780846881) practices interventional cardiology in the Joplin, MO-KS market, with the plurality of this provider's patient population coming from Jasper, MO. This provider's primary affiliated billing organization is MERCY CLINIC JOPLIN LLC (NPI: 1215264817; TIN: 611604897) and primary practice location at 64804-4524. Ansari is affiliated with the CommonSpirit ACO I (ACO ID: A2164), Mercy Health ACO, LLC (ACO ID: A2616), Caravan Collaborative Pathways (ACO ID: A4604), and Aledade 151 Northern Territories MSSP Enhanced (ACO ID: A5349), participating under the MSSP model.

Ansari's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 791 traditional Medicare patients, billed 1,489 HCPCS/CPT codes, and received $81,226 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,621 prescription claims across 321 beneficiaries totaling $444,620 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2022 DME data shows 72 claims. Open Payments data shows 47 records totaling $2,484. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $37,900 and ending at $81,226. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $34,207 to $444,620. In contrast, DME billing represents a smaller volume and rose steadily, from $793 to $15,941.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	198	456	$37,900
2016	836	2,077	$135,180
2017	1,153	3,020	$149,955
2018	991	2,830	$150,579
2019	1,214	2,994	$164,603
2020	819	1,820	$91,887
2021	1,352	4,116	$484,381
2022	1,640	4,825	$493,132
2023	527	1,671	$111,852
2024	791	1,489	$81,226

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	166	$34,207
2016	231	1,426	$64,340
2017	368	2,949	$177,353
2018	411	3,717	$309,386
2019	502	4,127	$288,844
2020	508	4,386	$346,380
2021	333	1,039	$117,386
2022	293	1,488	$351,707
2023	318	2,000	$454,010
2024	321	2,621	$444,620

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	80	$3,324
2019	16	191	$7,679
2020	32	292	$14,625
2021	N/R	154	$8,939
2022	N/R	72	$4,212
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	105	155	$80
93312	Ultrasound of heart with probe in esophagus, with report	30	37	$79
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	222	225	$50
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	33	33	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	445	487	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	128	6,234	$116,226
Eliquis	Apixaban	133	5,550	$107,860
Entresto	Sacubitril/Valsartan	102	4,660	$96,135
Xarelto	Rivaroxaban	43	2,655	$45,032
Brilinta	Ticagrelor	32	1,350	$19,747

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	47	$2,484	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Julia G. Ansari, M.D.?

Tedicare shows public-source Medicare data for Julia G. Ansari, M.D. (NPI 1780846881), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Julia G. Ansari, M.D. have ACO affiliation data?

Julia G. Ansari, M.D. is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164), Mercy Health ACO, LLC (MSSP, ACO ID A2616), Caravan Collaborative Pathways (MSSP, ACO ID A4604), and Aledade 151 Northern Territories MSSP Enhanced (MSSP, ACO ID A5349).

What billing organization is linked to Julia G. Ansari, M.D.?

Julia G. Ansari, M.D. is linked to MERCY CLINIC JOPLIN LLC (billing NPI 1215264817) in the available physician profile data.

Does Julia G. Ansari, M.D. have Open Payments data?

Julia G. Ansari, M.D. has 47 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.